| 000 | 01153 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250513112044.0 | ||
| 264 | 0 | _c19970417 | |
| 008 | 199704s 0 0 eng d | ||
| 022 | _a0163-4356 | ||
| 024 | 7 |
_a10.1097/00007691-199702000-00014 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTammara, V | |
| 245 | 0 | 0 |
_aA limited sampling method for the estimation of vigabatrin maximum plasma concentration and area under the curve. _h[electronic resource] |
| 260 |
_bTherapeutic drug monitoring _cFeb 1997 |
||
| 300 |
_a79-82 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 |
_aAnticonvulsants _xblood |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aRenal Insufficiency _xblood |
| 650 | 0 | 4 | _aVigabatrin |
| 650 | 0 | 4 |
_agamma-Aminobutyric Acid _xanalogs & derivatives |
| 700 | 1 | _aMahmood, I | |
| 700 | 1 | _aYu, D K | |
| 700 | 1 | _aHileman, G A | |
| 773 | 0 |
_tTherapeutic drug monitoring _gvol. 19 _gno. 1 _gp. 79-82 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00007691-199702000-00014 _zAvailable from publisher's website |
| 999 |
_c9019156 _d9019156 |
||